Author:
Bazargan Maryam,Davey Andrew K.,Muhlhausler Beverly S.,Morrison Janna L.,McMillen I. Caroline,Foster David J.R.
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference18 articles.
1. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists;Olefsky;J. Clin. Invest.,2000
2. Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM;Iwamoto;Diabetes Care,1991
3. Avandia (rosiglitazone maleate) [prescribing information], Research Triangle Park, NC: GlaxoSmithKline, 2005, p. 16.
4. Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin;Hemauer;Am. J. Obstet. Gynecol.,2010
5. Rosiglitazone increases the expression of peroxisome proliferator-activated receptor-gamma target genes in adipose tissue, liver, and skeletal muscle in the sheep fetus in late gestation;Muhlhausler;Endocrinology,2009
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献